Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of and .

The rise in antimicrobial resistant bacteria is limiting the number of effective treatments for bacterial infections. and are two of the pathogens with the highest prevalence of resistance, and with the greatest need for new antimicrobial agents. Combinations of antimicrobial peptides (AMPs) and antibiotics that display synergistic effects have been shown to be an effective strategy in the development of novel therapeutic agents.